Evidence map›Paper›PMID 40556853›Full record

ArticleQatar medical journal2025

Cerebral venous sinus thrombosis as a complication of heparin-induced thrombocytopenia in myasthenia gravis: A rare and complex case.

Majd A AbuAlrob, Abdullah Mantawil Gumander, Khaled Zammar, Abdullah I Al Qazakzeh, Sadi Y Alnakhala, Osama M Khalil, Suhail Hussain

Abstract readCase Reports
In one paragraph

Article in Qatar medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Majd A AbuAlrobNeuroscience Institute, Hamad Medical Corporation, Doha, Qatar.
Abdullah Mantawil GumanderDepartment of Medicine, Hamad General Hospital, Doha, Qatar *Email: majdaiabualrob72@gmail.com.
Khaled ZammarNeuroscience Institute, Hamad Medical Corporation, Doha, Qatar.
Abdullah I Al QazakzehDepartment of Medicine, Hamad General Hospital, Doha, Qatar *Email: majdaiabualrob72@gmail.com.
Sadi Y AlnakhalaDepartment of Medicine, Hamad General Hospital, Doha, Qatar *Email: majdaiabualrob72@gmail.com.
Osama M KhalilDepartment of Medicine, Hamad General Hospital, Doha, Qatar *Email: majdaiabualrob72@gmail.com.
Suhail HussainNeuroscience Institute, Hamad Medical Corporation, Doha, Qatar.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cerebral venous sinus thrombosis (CVST) is an uncommon yet critical complication, especially when arising from heparin-induced thrombocytopenia (HIT). In patients with preexisting conditions such as myasthenia gravis (MG), this correlation adds further complexity to clinical management and outcomes. Case presentation: We report a unique case of CVST induced by HIT in a patient with an established diagnosis of MG. Following plasma exchange therapy, which included heparin administration, the patient developed symptoms indicative of CVST. Diagnostic imaging confirmed thrombosis in the cerebral venous sinuses. Management involved the immediate discontinuation of heparin and the initiation of fondaparinux, leading to effective anticoagulation and clinical improvement. Discussion: This case illustrates the rare intersection of CVST and HIT within the context of MG, underscoring the potential risks associated with heparin therapy in vulnerable patient populations. Early recognition of the signs is essential, as these conditions, in combination, demand prompt and specialized interventions to prevent serious complications. Conclusion: The successful management of this complex case demonstrates the importance of heightened awareness and proactive strategies in patients with MG undergoing heparin therapy. This report advocates for careful monitoring and tailored treatment to mitigate risks in similarly complex clinical scenarios.

Indexed as

Cerebral venous sinus thrombosisheparin included thrombocytopenia myasthenia gravis

Identifiers

PMID40556853
PMCPMC12183653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.